Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Supplementation for Prevention of PD-related Peritonitis
NCT03264625Phase 2Completed
- Sponsor
- Peking University First Hospital
- Start
- Sep 2017
- Primary completion
- May 2021
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of vitamin d in peritonitis (2 arms), sponsored by Peking University First Hospital. Primary endpoints: Recruitment rate of the trial at 1 year, Retention rate of the trial at 1 year and 3 more. Started Sep 2017; status: completed.
02
Drugs
vitamin d
03
Conditions
peritonitis
Beyond the preview
Go deeper on NCT03264625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03264625.